Signal-3 Research Bundle
Signal-3 Research Bundle
Crypto
Restock in progress. Add your email and we will tell you the moment this compound is back in stock.
One email when this is back in stock. No spam, unsubscribe anytime.
Product details
Signal-3 Research Bundle is supplied for qualified laboratory research use only.
Product documentation may include identity, nominal fill, purity, lot number, retest or expiry date, and a lot-specific Certificate of Analysis (COA), where available.
Not intended for diagnostic, therapeutic, clinical, food, cosmetic, household, or personal-use applications. Not intended for use outside qualified laboratory research.
Complete your order
supplied for laboratory research only
Recently viewed
picks up where you left off
Research
Each compound in this set has been characterised in preclinical laboratory models. The primary studies below, in animal and in-vitro models, examined cellular, biochemical, and mechanistic endpoints. The literature is preclinical: it describes the compounds, not any outcome in humans.
5 preclinical studies indexed · cjc-1295 dac, ipamorelin and tesamorelin · links open on PubMed
CJC-1295 DAC 2 studies
Animal modelHuman growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analogIn cultured rat anterior-pituitary cells and rats, the albumin-bioconjugated analog activated the GRF receptor and extended plasma residence.Read the study ↗
Animal modelOnce-daily CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouseIn GHRH-knockout mice, the analog raised pituitary GH mRNA and somatotroph number via the GH/IGF-1 axis.Read the study ↗
Ipamorelin 2 studies
Animal and in vitroIpamorelin characterised as a selective growth hormone secretagogue receptor agonistIn primary rat pituitary cell cultures and in anaesthetised rats and conscious swine, receptor-binding and concentration-response assays measured growth hormone secretion at the growth hormone secretagogue receptor, with the response gauged against parallel ACTH and cortisol measurements across the exposure range tested as a selectivity endpoint.Read the study ↗
Animal modelIpamorelin and GH-releasing peptide-6 assayed against bone mineral content in an adult female rat modelIn adult female rats assayed against vehicle controls over a multi-week period, the study measured body weight change and total and cortical bone mineral content by densitometry and chemical analysis as physiological endpoints, comparing ipamorelin with GH-releasing peptide-6.Read the study ↗
Links open the original study on PubMed. For research and educational purposes, descriptive of the published preclinical literature, not therapeutic claims about any ai-peptides product. A Certificate of Analysis and a Safety Data Sheet are available on request for every batch.
Reviews
Verified-order reviews on service, shipping, and product quality appear here once the first order is reviewed.
